Join us on March 30 for the third RISE workshop, "RISE Together: Data Sharing Across the Rare Disease Ecosystem." This event will explore data sharing as it pertains to informing development and regulatory review for rare disease therapies. Space is filling fast! Register today: duke.is/2/t6dr

There’s still time to register! The 10th Anniversary of the HCPLAN: Celebrating a Decade of Advancing Value-Based Care virtual event takes place on 2/2 from 2-4pm ET. Hear from Mark McClellan as speakers reflect on a decade of progress and look toward the future. Register today: bit.ly/4qzHuP0

Looking for resources to support accountable care transformation? The West Health & Duke-Margolis Accelerator website hosts a body of health policy research driven by our partnership with West Health as we have sought to advance better care across the U.S. health system: www.acceleratecare.org/

Bass Connections project teams for 2026-27 have been announced! Several research projects fall under the Health Policy and Innovation theme, covering issues such as accessible housing, child and family health, advancing health education, and more. Applications are open until 2/9! duke.is/z/vxcj

Our first event of 2026 has been announced! Join us for a webinar on 2/19 to learn more about how rapid learning can be used to accelerate accountable care. In particular, we will discuss CMMI's RCIP as well as Duke-Margolis and West Health's Accountable Care Learning Hub. Register: duke.is/6/ef23

Welcome back, Duke students! Don't forget that our Undergraduate Scholar applications are open until 1/12. Our Margolis Scholars program is a great supplement to your degree program that can provide you with the competencies needed for a career in health policy: healthpolicy.duke.edu/scholars

Congratulations to our real-world evidence team! Last week, Duke-Margolis researchers presented posters at the Duke Precision Genomics Collaboratory Scientific Retreat. One poster won a best poster award and research grant! Read the paper from the winning poster here: duke.is/5/ygcs

Our last event of 2025 is just a few days away—don't miss your chance to register! Join us next Tuesday, December 16, in our DC office as speakers explore ways to improve access to epinephrine and reduce anaphylaxis-related morbidity and mortality. Learn more and register here: duke.is/y/x7xs

How can Medicaid agencies continue to make progress on community health and well-being in today’s policy environment? A new issue brief drawing on community-based research published with @dukemargolis.bsky.social identifies 6 strategies.

Core Faculty member Matt Maciejewski has co-authored a JAMA Viewpoint article that discussed how real-world evidence studies can be best used to inform Medicare drug price negotiations. Read the authors' guidance here: duke.is/n/7r2w

Institute Director Mark McClellan and 11 other former U.S. Food and Drug Administration Commissioners express their concern for recently announced changes in the FDA’s regulatory model for vaccines in a new article published by the New England Journal of Medicine. Read more here: duke.is/w/7bqt

Institute Director Mark McClellan and Research Director Christina Silcox have released a statement on the new CMS ACCESS Model, which aims to improve the health of people with chronic disease and covered by Traditional Medicare, through technology-supported care. Read our statement: duke.is/j/tqrq

A summary of the recent Duke Climate Collaboration Symposium focused has been published! Co-hosted by Duke-Margolis & the School of Medicine, the event convened leaders across disciplines to explore how the health care landscapes can adapt and lead in the face of a changing climate: duke.is/w/yu9h

Duke-Margolis researchers Montgomery Smith and Frank McStay co-authored a paper in the Journal of the American Medical Directors Association that studied stakeholder feedback on the potential development of a home-based primary care practice recognition program: duke.is/n/tvd2

Join us this Thursday for our hybrid workshop, "Individualized Therapies on the RISE." In this second installment of the FDA's RISE workshop series, speakers will explore the emerging science and regulatory environment for individualized medicine programs. Registration closes soon: duke.is/m/jxxj

Mark McClellan discussed how health care leaders can build a more sustainable future during the 2025 Health Evolution Summit. Learn more about Mark's and his fellow speakers' thoughts in the Summit recap: duke.is/m/zntv

Our next event is days away! Join us on November 18 for a webinar that will explore how to build a sustainable, value-driven roadmap for HBPC within Medicare. Registration closes soon, so don't forget to secure your spot in the conversation: duke.is/9/ct26

Duke-Margolis researchers have co-authored a paper in the North Carolina Medical Journal to discuss the history of bipartisan support for NC Medicaid, highlight examples of lessons learned and impacts, and offer key considerations for the path forward. Read more here: duke.is/r/gge5

With the homebound population growing, how do we build the roadmap for better home-based primary care? A draft agenda is now available for our upcoming webinar, where speakers will explore solutions to this question. Join us on November 18 for this important conversation: duke.is/9/ct26

Hear from Assistant Research Director Frank McStay next week at the PCC's 2025 Evidence Report release! On 11/12, Frank and his fellow speakers will examine the state of rural primary care as residents of rural communities face new barriers to health coverage: thepcc.pub/Closing-The-Distance

In this new Health Affairs Forefront article, Duke-Margolis researchers explore opportunities to advance rapid learning for accountable care. In particular, they highlight the potential of collaborative action through efforts like the new West Health Accelerator at Duke-Margolis: duke.is/r/w5uz

Duke-Margolis has published an event report for "On the RISE: Controls in Rare Disease Clinical Trials for Small and Diminishing Populations" that summarizes the discussion that took place, offers key takeaways, and outlines next steps. You can read it here: duke.is/z/mkv3

Don't miss your chance to join this conversation! Tomorrow, we are gathering health policy experts and leaders across the public and private sectors to discuss the vision for accountable care reform, and chart a path toward delivering better health and better care for all: duke.is/p/3vx6

Drug shortages have severely impacted patient care in the U.S. for decades. In our latest white paper, Duke-Margolis researchers propose next steps that Congress can take to address the root causes of the drug shortage problem + create a more reliable & resilient supply chain: duke.is/6/mduj

Institute Director Mark McClellan and Policy Analyst Sara Debab have co-authored a new Viewpoint article in JAMA Health Forum to outline steps that reduce clinician burnout by modernizing Medicare’s risk adjustment mechanism. Read their recommendations here: duke.is/w/tdna

A new event has been announced! Don't miss this webinar coming up on November 18, where speakers will explore opportunities to advance home-based primary care. Learn more and register here: duke.is/9/ct26

@michellescotton.bsky.social @dukemargolis.bsky.social sharing our engagement project learnings with researchers and patient advocates at #PCORI25

Learn more about the current state and future of the Sentinel Initiative in our upcoming workshop, convened with the FDA. A draft agenda is now available and contains more details about the topics of discussion—you can read it and register to attend here: duke.is/z/wdhk

A draft agenda is now available for our upcoming workshop, "Individualized Therapies on the RISE"! Co-convened with the FDA, this event will explore the regulatory considerations surrounding individualized therapies that can help treat rare diseases. Read the agenda + register here: duke.is/m/jxxj

Our next event is just around the corner! We invite you to join us in DC for a timely conversation on accountable care reform. With new technological advances, policy shifts, and the lessons learned from the last decade, the next chapter of accountable care starts now: duke.is/p/3vx6

A new hybrid workshop has been announced! Join us at the Duke in DC office on December 16 as speakers discuss ways to expand epinephrine accessibility and use, including in community settings, to reduce anaphylaxis-related morbidity and mortality. Learn more and register here: duke.is/y/x7xs

Don't miss our Open House this Friday! Join us in our Durham office to learn more about how the Institute's research and educational initiatives help engage students across campus in health policy. We're hosting this event as part of Duke's Family Weekend: duke.is/n/x6w2

In just a few weeks, we are hosting the Seventeenth Annual Sentinel Initiative Public Workshop with the FDA. Join us at the FDA's White Oak Campus in Maryland to learn more about the initiative's work so far as well as future directions. Register today: duke.is/z/wdhk

Join us in DC for a new workshop, "Individualized Therapies on the RISE," coming up on November 20. During this event, speakers will examine the emerging science and regulatory environment for individualized medicine programs. Learn more and register here: duke.is/m/jxxj

Join us next Friday, 10/ 17, for our Open House! This event is an opportunity to meet the educators and mentors who are working with Duke students, and to learn more about how the Institute's research and educational initiatives help engage students across campus in health policy: duke.is/n/x6w2

Don't miss this upcoming event! On November 6, we are hosting the Seventeenth Annual Sentinel Initiative Public Workshop with the FDA. Each year, this event showcases the work of the Sentinel Initiative to-date, along with future-looking discussions: duke.is/z/wdhk

Accountable care—centered on personalized, coordinated, and whole-person care—is no longer the vision for the future of the American Health system: it is here, now. Join us next month for an event that will launch the new West Health Accelerator at Duke-Margolis: duke.is/p/3vx6

Don't miss the upcoming Duke Climate Collaboration Symposium! On 10/1, speakers will explore opportunities to reduce health care greenhouse gas emissions and implement reforms to mitigate the health impacts of climate change: duke.is/y/s33v

CMS Administrator Mehmet Oz and Duke-Margolis Director Mark McClellan will discuss CMS' vision and strategies during an upcoming event hosted by The Aspen Institute. Join in-person or virtually next Wednesday, September 24, to learn more! You can register to attend here: duke.is/b/49j5

Join us tomorrow for our next hybrid workshop! Speakers will explore novel efficacy endpoints used in interventional clinical trials for drugs and biological products intended for patients with severe vision loss. A discussion guide is now available—you can read it and register here: duke.is/6/jzzn

In our newest white paper, Duke-Margolis researchers share policy recommendations to strengthen drug supply chain security and resilience, including through the establishment of an international biopharmaceutical coalition. Read more here: duke.is/j/pevx

On 10/7, the Duke Center of Global Mental Health is hosting their 2025 conference, "Now More than Ever: Addressing the Global Imperative of Mental Health Equity." Registration is free and all are welcome to attend: sites.duke.edu/dukegmhconf2025/

📣JUST PUBLISHED: Our white paper on regulatory opportunities to advance generic drug repurposing is now available online! This paper explores the role of the regulator and policy actions it can take to support repurposing initiatives. @dukemargolis.bsky.social healthpolicy.duke.edu/publications...

Duke-Margolis researchers have co-authored a paper in the Journal of Pharmacy & Pharmaceutical Sciences on pharmacogenomics (PGx) testing data. They noted that improving racial and genetic ancestry data, and increasing interoperability with EHRs, could make PGx data more actionable: duke.is/5/ygcs

Don't miss your chance to register! Next Wednesday, September 3, we're hosting a workshop with the FDA to discuss control options in rare disease clinical trials. A final agenda and speaker bios have been posted to the event webpage—you can read them and register here: duke.is/z/mkv3

Speakers have been announced for our upcoming virtual workshop! On 9/10, hear from FDA officials and health policy experts as we discuss challenges and strategies for expedited chemistry, manufacturing, and controls development. Learn more about our speakers and register here: duke.is/n/eef3

Our next event is right around the corner! On 9/3, we're hosting a hybrid workshop with the FDA to explore control options for rare disease clinical trials. Though we have reached capacity for in-person registration, we invite you to join the waitlist or register to attend virtually: duke.is/z/mkv3

A draft agenda is now available for our workshop on 9/17, where speakers will discuss clinical trial endpoints for drugs and biological products intended for patients with severe vision loss. Join us in DC to discuss this critical topic and network with your peers: duke.is/6/jzzn

Join FDA & Duke-Margolis Sept. 23 at the National Press Club for a free, hybrid public workshop that will discuss examples in which real-world evidence was used for regulatory decision-making for medical products. Register today: duke.is/y/7nyz

Hear from Institute Director Mark McClellan at a special edition of the Virtual Value-Based Payment Summit. Mark and his fellow speakers will discuss the future of Medicare value-based care during the closing fireside chat on 9/5. Learn more and register here: valuebasedpaymentsummit.com/